| Literature DB >> 26331125 |
Jong Kil Nam1, Hyeon Woo Kim2, Dong Hoon Lee1, Ji-Yeon Han1, Jeong Zoo Lee2, Sung-Woo Park3.
Abstract
PURPOSE: To investigate the factors associated with the occurrence of and recovery from transient urinary incontinence (TUI) after holmium laser enucleation of the prostate (HoLEP).Entities:
Keywords: Lasers; Prostatic hyperplasia; Urinary incontinence
Year: 2015 PMID: 26331125 PMCID: PMC4550601 DOI: 10.5534/wjmh.2015.33.2.88
Source DB: PubMed Journal: World J Mens Health ISSN: 2287-4208 Impact factor: 5.400
Fig. 1Recovery ratio of transient urinary incontinence depending on its duration. Eighty percent of the patients who complained transient urinary incontinence after holmium laser enucleation of the prostate showed recovery within 3 months from the date of the surgery (n=65).
Baseline characteristics and perioperative data
| Variable | Patients without TUI (n=326) | Patients with TUI (n=65) | p value |
|---|---|---|---|
| Baseline characteristic | |||
| Age (yr) | 65.3±7.2 | 68.8±6.5 | <0.001 |
| Diabetes | 65 | 14 | 0.764 |
| Prostate volume (mL) | 54.1±25.2 | 50.7±20.1 | 0.307 |
| International Prostate Symptom Score | |||
| Voiding symptoms | 10.4±5.4 | 12.9±5.0 | 0.007 |
| Storage symptoms | 6.8±3.8 | 8.1±3.6 | 0.051 |
| Total score | 17.2±8.4 | 21.0±7.6 | 0.009 |
| Quality of life score | 3.9±1.3 | 4.5±1.4 | 0.019 |
| Overactive Bladder Symptom Score | 5.6±3.3 | 7.1±3.3 | 0.074 |
| Max flow rate (mL/s) | 12.9±14.5 | 10.2±5.2 | 0.211 |
| Postvoid residual urine (mL) | 60.1±67.9 | 95.7±148.5 | 0.013 |
| Serum PSA (ng/mL) | 5.3±10.6 | 4.5±5.3 | 0.545 |
| Perioperative data | |||
| Total operation time (min) | 59.1±36.0 | 81.7±50.9 | <0.001 |
| Morcellation time (min) | 14.9±16.2 | 19.7±21.5 | 0.040 |
| Resected volume (mL) | 23.1±20.0 | 25.6±18.4 | 0.352 |
Values are presented as mean±standard deviation or number only.
TUI: transient urinary incontinence, PSA: prostate-specific antigen.
Univariate and multivariate predictors of postoperative transient incontinence
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value | |
| Age (<65 vs. ≥65), yr | 2.85 (1.55~5.21) | 0.001 | 3.49 (1.57~7.80) | 0.002 |
| Prostate volume (<50 vs. ≥50), g | 0.98 (0.53~1.80) | 0.940 | 0.89 (0.49~1.25) | 0.489 |
| International Prostate Symptom Score (<17 vs. ≥17) | 1.98 (1.00~3.98) | 0.047 | 1.61 (0.74~3.46) | 0.228 |
| Overactive Bladder Symptom Score (<5 vs. ≥5) | 1.73 (0.57~5.25) | 0.330 | - | - |
| Max flow rate (<13 vs. ≥13), mL/s | 0.64 (0.31~1.34) | 0.644 | - | - |
| Postvoid residual urine (<70 vs. ≥70), mL | 1.45 (0.71~2.94) | 0.299 | - | - |
| Total operation time (<65 vs. ≥65), min | 2.17 (1.26~3.72) | 0.005 | 3.85 (1.61~9.19) | 0.002 |
CI: confidence interval.